APRINOIA THERAPEUTICS’ DIAGNOSTIC TOOL RECEIVES FAST TRACK DESIGNATION FROM FDA
KUALA LUMPUR, APRINOIA Therapeutics Inc (APRINOIA) announced the United States (US) Food and Drug Administration (FDA) recently granted Fast Track Designation (FTD) to APN-1607, a Positron Emission Tomography (PET) tracer for imaging tau protein in pa…